Skip to content

Blended Unified Protocol for Chinese Adolescents With Non-Suicidal Self-Injury: A Randomized Controlled Trial

A Randomized Controlled Trial Evaluating the Efficacy of a Blended Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Chinese Adolescents With Non-Suicidal Self-Injury

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07110181
Enrollment
60
Registered
2025-08-07
Start date
2025-08-15
Completion date
2026-06-20
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-suicidal Self-injury (NSSI)

Keywords

non-suicidal self-injury, adolescent

Brief summary

This study is an open-label, randomized controlled trial evaluating the efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) in reducing non-suicidal self-injury (NSSI) among Chinese adolescents. This program is an annualized cognitive-behavioral therapy designed for adolescents aged 12-17 years who engage in non-suicidal self-injury behavior. Its primary goal is to reduce the intensity and frequency of distressing emotional experiences by teaching adolescents how to confront and respond to these emotions in more adaptive ways. In turn, this helps reduce self-injury impulses and behaviors. The UP-A is adapted to the Chinese cultural context and delivered as a blended treatment, combining face-to-face and online sessions.

Interventions

Participants in the control group will receive treatment as usual, including pharmacotherapy and routine clinical follow-up, as determined by their treating psychiatrists.

BEHAVIORALa blended version of the Unified Protocol for Adolescents (UP-A)

The blended UP-A includes 8 weekly modules, 6 of which (Modules 2 - 7)are online self-guided sessions. The online self-guided sessions will last approximately 45 minutes each. Over the course of these 6 weeks, participants will also have 6 therapist-guided online sessions via videoconference, each lasting 30 minutes. Two face-to-face individual sessions are scheduled, one at the beginning of each (Module 1) and one at the end (Module 8), each with an expected duration of 90 minutes.

Sponsors

Jian-Jun Ou
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Aged between 12 and 17 years; 2. Engaged in non-suicidal self-injury (NSSI) at least 5 times in the past 12 months, with at least 1 episode in the past month; 3. Minimum education level of primary school or above; 4. Participant and guardian fully understand the research content and agree to participate, with signed informed consent provided.

Exclusion criteria

1. Suicide attempts in the past month or a score of ≥17 on the MINI National Neuropsychiatric Interview for Children (MINI KID 5.0), indicating a high risk of suicide; 2. Diagnosis of a psychotic disorder, autism spectrum disorder, or other serious neurodevelopmental disorders according to the DSM-5; 3. Presence of severe physical illness or other medical conditions that may affect the completion of treatment and evaluation; 4. Currently receiving other professional psychotherapy or participating in another NSSI intervention study; 5. Received 5 or more sessions of cognitive behavioral therapy (CBT) in the past 5 years; 6. Having received electroconvulsive therapy (ECT) within the past 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Non-suicidal self-injury behaviorUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)The Adolescent Self-Harm Behavior Scale includes 18 items describing forms of self-harm. The scale is divided into two dimensions: frequency and severity of self-harm. Self-harm frequency is scored on a 4-point scale (0-3), with the following categories: 0 times, 1 time, 2-4 times, and more than 5 times. The severity of physical injury is scored on a 5-point scale (0-4), with the following categories: none, mild, moderate, severe, and extremely severe. The product of frequency and injury severity for each item is used as the overall score for NSSI, with higher scores indicating more severe NSSI behavior.

Secondary

MeasureTime frameDescription
DepressionUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)The Patient Health Questionnaire-9 (PHQ-9) was used to measure depression levels. This nine-item scale rates each item on a four-point scale from 0 (not at all) to 3 (nearly every day), with total scores ranging from 0 to 27. Higher scores indicate greater depression severity.
AnxietyUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)The Generalized Anxiety Disorder-7 (GAD-7) was used to assess anxiety levels of participants. This seven-item scale also employs a four-point scoring system from 0 (not at all) to 3 (nearly every day), with higher scores reflecting greater anxiety severity.

Other

MeasureTime frameDescription
NeuroticismUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)The Neuroticism subscale from the Neuroticism-Extraversion-Openness Five-Factor Inventory was selected to measure neuroticism. The Neuroticism subscale consists of 12 items, rated on a 5-point Likert scale. Higher scores indicate a stronger tendency toward neuroticism in the individual.
Distress toleranceUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)The Distress Tolerance Scale (DTS) is a 15-item measure of an individual's perceived ability to withstand negative emotions. Items are answered on a five-point Likert scale ranging from 1 = strongly agree to 5 = strongly disagree. Traditionally, high DTS-global distress intolerance scores reflect a heightened ability to tolerate distress, whereas low total scores represent distress intolerance.
Emotion regulation strategiesUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)The Emotion Regulation Questionnaire (ERQ) is used to measure participants' emotional regulation strategies. It consists of 10 items, divided into two dimensions: cognitive reappraisal and expressive suppression. Each item is rated on a 7-point scale, with higher scores indicating a stronger tendency to use the corresponding emotional regulation strategy.
Emotion dysregulationUp to 3 months post-baseline (measured at baseline, 1, 2, and 3 months)Difficulties in Emotion Regulation Scale (DERS) is used to assess the participants' emotional regulation abilities. It consists of 36 items across 6 dimensions, with higher total scores indicating a higher level of emotional dysregulation. The dimensions include: emotional awareness, emotional acceptance, impulse control, emotional understanding, goal-directed behavior, and strategy use.

Countries

China

Contacts

Primary ContactJianjun Ou, PhD
oujianjun@csu.edu.cn+8617775861486

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026